Home Healthcare Biotechnology Biopharmaceutical Excipients Market

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Excipient (Bulking Agents, Solubilizers and Surfactants, Buffering and Tonicity Agents, Others), By Biologics (Monoclonal Antibodies, Vaccines, Others), By Scale of Operation (Commercial, Research), By End-User (Pharma and Biotech Companies, CMOS and CDMOS, Academic and Research Institutes) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR3549DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Biopharmaceutical Excipients Market, By Excipient 2022-2034 (USD MILLION/ Units)
    1. Bulking Agents
    2. Solubilizers and Surfactants
    3. Buffering and Tonicity Agents
    4. Others
  2. Biopharmaceutical Excipients Market, By Biologics 2022-2034 (USD MILLION/ Units)
    1. Monoclonal Antibodies
    2. Vaccines
    3. Others
  3. Biopharmaceutical Excipients Market, By Scale of Operation 2022-2034 (USD MILLION/ Units)
    1. Commercial
    2. Research
  4. Biopharmaceutical Excipients Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharma and Biotech Companies
    2. CMOS and CDMOS
    3. Academic and Research Institutes
  5. Regional Biopharmaceutical Excipients Market
    1. North America
      1. North America Biopharmaceutical Excipients Market By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      2. North America Biopharmaceutical Excipients Market By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      3. North America Biopharmaceutical Excipients Market By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      4. North America Biopharmaceutical Excipients Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
      5. U.S.
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      6. Canada
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
    2. Europe
      1. Europe Biopharmaceutical Excipients Market By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      2. Europe Biopharmaceutical Excipients Market By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      3. Europe Biopharmaceutical Excipients Market By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      4. Europe Biopharmaceutical Excipients Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
      5. U.K.
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      6. Germany
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      7. France
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      8. Spain
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      9. Italy
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      10. Russia
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      11. Nordic
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      12. Benelux
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      13. Rest of Europe
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
    3. APAC
      1. APAC Biopharmaceutical Excipients Market By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      2. APAC Biopharmaceutical Excipients Market By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      3. APAC Biopharmaceutical Excipients Market By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      4. APAC Biopharmaceutical Excipients Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
      5. China
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      6. Korea
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      7. Japan
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      8. India
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      9. Australia
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      10. Taiwan
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      11. South East Asia
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      12. Rest of Asia-Pacific
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Biopharmaceutical Excipients Market By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      2. Middle East and Africa Biopharmaceutical Excipients Market By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      3. Middle East and Africa Biopharmaceutical Excipients Market By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      4. Middle East and Africa Biopharmaceutical Excipients Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
      5. UAE
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      6. Turkey
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      7. Saudi Arabia
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      8. South Africa
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      9. Egypt
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      10. Nigeria
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      11. Rest of MEA
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
    5. LATAM
      1. LATAM Biopharmaceutical Excipients Market By Excipient 2022-2034 (USD MILLION/ Units)
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
      2. LATAM Biopharmaceutical Excipients Market By Biologics 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Vaccines
        3. Others
      3. LATAM Biopharmaceutical Excipients Market By Scale of Operation 2022-2034 (USD MILLION/ Units)
        1. Commercial
        2. Research
      4. LATAM Biopharmaceutical Excipients Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharma and Biotech Companies
        2. CMOS and CDMOS
        3. Academic and Research Institutes
      5. Brazil
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      6. Mexico
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      7. Argentina
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      8. Chile
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      9. Colombia
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
      10. Rest of LATAM
        1. Bulking Agents
        2. Solubilizers and Surfactants
        3. Buffering and Tonicity Agents
        4. Others
        5. Monoclonal Antibodies
        6. Vaccines
        7. Others
        8. Commercial
        9. Research
        10. Pharma and Biotech Companies
        11. CMOS and CDMOS
        12. Academic and Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.